Repeat Targeted Prostate Biopsy under Guidance of Multiparametric MRI-Correlated Real-Time Contrast-Enhanced Ultrasound for Patients with Previous Negative Biopsy and Elevated Prostate-Specific Antigen: A Prospective Study.

To prospectively determine whether multi-parametric MRI (mpMRI) - contrast-enhanced ultrasound (CEUS) correlated, imaging-guided target biopsy (TB) method could improve the detection of prostate cancer in re-biopsy setting of patients with prior negative biopsy.

From 2012 to 2014, a total of 42 Korean men with a negative result from previous systematic biopsy (SB) and elevated prostate-specific antigen underwent 3T mpMRI and real-time CEUS guided TB. Target lesions were determined by fusion of mpMRI and CEUS. Subsequently, 12-core SB was performed by a different radiologist. We compared core-based cancer detection rates (CaDR) using the generalized linear mixed model (GLIMMIX) for each biopsy method.

Core-based CaDR was higher in TB (17. 92%, 38 of 212 cores) than in SB (6. 15%, 31 of 504 cores) (p < 0. 0001; GLIMMIX). In the cancer-positive TB cores, CaDR with suspicious lesions by mpMRI was higher than that by CEUS (86. 8% vs. 60. 5%, p= 0. 02; paired t-test) and concordant rate between mpMRI and CEUS was significantly different with discordant rate (48% vs. 52%, p=0. 04; McNemar's test).

The mpMRI-CEUS correlated TB technique for the repeat prostate biopsy of patients with prior negative biopsy can improve CaDR based on the number of cores taken.

PloS one. 2015 Jun 17*** epublish ***

Dong Ryul Jang, Dae Chul Jung, Young Taik Oh, Songmi Noh, Kyunghwa Han, Kiwook Kim, Koon-Ho Rha, Young Deuk Choi, Sung Joon Hong

Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Pathology, Cha Medical College, Gang-Nam Cha Hospital, Seoul, Republic of Korea. , Avison Biomedical Research Center; Department of Radiology; Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Radiology, Severance Hospital, Research Institute of Radiological Science, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. , Department of Urology, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.

PubMed    Full Text Article

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe